Technical Report: Efficacy and Safety of Low-Intensity Transcranial Magnetic Stimulation in the Remission of Depressive Symptoms in Patients With Treatment-Resistant Depression in Mexico.

Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique that induces action potentials in the stimulated cortical area and has been approved by the Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD). The prevalence of MDD in Mexico almost tripled after the COVID-19 pandemic. In this study, we evaluated the safety and therapeutic effects of low-intensity TMS (Li-TMS) - characterized by inducing electric currents below the action potential threshold on the cerebral cortex - in 41 subjects diagnosed with treatment-resistant depression (TRD).

Mental health of the Mexican population during the COVID-19 pandemic.

Introduction: The COVID-19 pandemic has also affected mental health.

Objective: To evaluate Mexican population mental health during the COVID-19 pandemic by measuring symptoms of stress, depression, anxiety and insomnia, as well as resilience.

Methods: Cross-sectional, descriptive, observational study.